| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.583 | 2.715 | 5.541 | 3.155 | 2.022 | 541 |
| Total Income - EUR | - | - | - | - | 3.844 | 2.814 | 5.193 | 3.155 | 2.022 | 541 |
| Total Expenses - EUR | - | - | - | - | 1.736 | 2.879 | 4.941 | 6.776 | 4.605 | 3.382 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.108 | -65 | 252 | -3.621 | -2.584 | -2.841 |
| Net Profit/Loss - EUR | - | - | - | - | 2.000 | -146 | 89 | -3.716 | -2.584 | -2.841 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Apibav S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 9.718 | 10.697 | 8.886 |
| Current Assets | - | - | - | - | 2.269 | 2.265 | 4.901 | 4.882 | 5.993 | 6.312 |
| Inventories | - | - | - | - | 261 | 355 | 831 | 2.830 | 2.583 | 3.905 |
| Receivables | - | - | - | - | 0 | 3 | 0 | 1.879 | 2.194 | 2.293 |
| Cash | - | - | - | - | 2.008 | 1.907 | 4.070 | 173 | 1.216 | 114 |
| Shareholders Funds | - | - | - | - | 2.042 | 1.858 | 1.905 | -1.805 | -4.383 | -7.200 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 227 | 407 | 2.995 | 16.404 | 21.073 | 22.398 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1629 - 1629" | |||||||||
| CAEN Financial Year |
1629
|
|||||||||
Comments - Apibav S.r.l.